Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin-GLP-1 RA vs Metformin-OC in Overweight PCOS
NCT03151005Phase 4Completed
- Sponsor
- Xinqiao Hospital
- Start
- Jul 2017
- Primary completion
- Apr 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of exenatide and liraglutide in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Xinqiao Hospital. Primary endpoint: Assessment of Reproductive Functions at 12 weeks. Started Jul 2017; status: completed.
02
Drugs
exenatideliraglutide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03151005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151005.